IP Library Granted Patent US 9,090,646
Granted Patent B2
US 9,090,646 · App. 14/096,845 · Granted Jul 28, 2015

Biotinylated compounds

Inventors: Roger A. Jones (New Brunswick, NJ); Barbara L. Gaffney (New Brunswick, NJ)
Assignee: Rutgers, The State University of New Jersey
C07H19/207C07H19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,090,646
App. No.
14/096,845
Granted
Jul 28, 2015
Kind
B2
Abstract

The invention provides new biotinylated compounds and methods for their use.

Claims (39)

1. A compound of formula I or formula II:

wherein:

each B is independently

X is (C 2 -C 8 )alkyl, (C 2 -C 8 )alkenyl or (C 2 -C 8 )alkynyl, wherein one or more carbon atoms of the (C 2 -C 8 )alkyl, (C 2 -C 8 )alkenyl or (C 2 -C 8 )alkynyl may be optionally replaced with one or more groups independently selected from O, S, C(═O) and NR a provided that the O, S or NR a are not adjacent to any other O, S or NR a , and wherein any (C 2 -C 8 )alkyl, (C 2 -C 8 )alkenyl or (C 2 -C 8 )alkynyl of X is optionally substituted with one or more groups independently selected from halogen, OR b and NR b 2 ;

Y is (C 2 -C 28 )alkyl, (C 2 -C 28 )alkenyl or (C 2 -C 28 )alkynyl, wherein one or more carbon atoms of the (C 2 -C 28 )alkyl, (C 2 -C 28 )alkenyl or (C 2 -C 28 )alkynyl may be optionally replaced with one or more groups independently selected from O, S, C(═O) and NR c provided that the O, S or NR c are not adjacent to any other O, S or NR c , and wherein any (C 2 -C 28 )alkyl, (C 2 -C 28 )alkenyl or (C 2 -C 28 )alkynyl of Y is optionally substituted with one or more groups independently selected from halogen, OR d and NR d 2 ;

W is O or S;

each R a is independently selected from H and (C 1 -C 6 )alkyl;

each R b is independently selected from H and (C 1 -C 6 )alkyl;

each R c is independently selected from H and (C 1 -C 6 )alkyl; and

each R d is independently selected from H and (C 1 -C 6 )alkyl;

or a salt thereof.

2. The compound of claim 1 , which is a compound of formula I:

or a salt thereof.

3. The compound of claim 1 , which is a compound of formula II:

or a salt thereof.

4. The compound of claim 1 , which is a compound of formula Ia:

or a salt thereof.

5. The compound of claim 1 , wherein each B is:

6. The compound of claim 1 , wherein each B is:

7. The compound of claim 1 , wherein W is O.

8. The compound of claim 1 , wherein X is (C 3 -C 8 )alkyl, (C 2 -C 8 )alkenyl or (C 2 -C 8 )alkynyl, wherein one or more carbon atoms of the (C 3 -C 8 )alkyl, (C 2 -C 8 )alkenyl or (C 2 -C 8 )alkynyl may be optionally replaced with one or more groups independently selected from O, S, C(═O) and NR a provided that the O, S or NR a are not adjacent to any other O, S or NR a , and wherein any (C 3 -C 8 )alkyl, (C 2 -C 8 )alkenyl or (C 2 -C 8 )alkynyl of X is optionally substituted with one or more groups independently selected from halogen, OR b and NR b 2 .

9. The compound of claim 1 , wherein X is (C 3 -C 8 )alkyl, wherein one or more carbon atoms of the (C 3 -C 8 )alkyl may be optionally replaced with one or more groups independently selected from O, S, C(═O) and NR a provided that the O, S or NR a are not adjacent to any other O, S or NR a .

10. The compound of claim 1 , wherein X is (C 2 -C 8 )alkyl, (C 2 -C 8 )alkenyl or (C 2 -C 8 )alkynyl.

11. The compound of claim 1 , wherein X is —(CH 2 ) 4 —.

12. The compound of claim 1 , wherein Y is (C 2 -C 28 )alkyl, (C 2 -C 28 )alkenyl or (C 2 -C 28 )alkynyl, wherein one or more carbon atoms of the (C 2 -C 28 )alkyl, (C 2 -C 28 )alkenyl or (C 2 -C 28 )alkynyl may be optionally replaced with one or more groups independently selected from O, S, C(═O) and NR c provided that the O, S or NR c are not adjacent to any other O, S or NR c .

13. The compound of claim 1 , wherein Y is (C 2 -C 28 )alkyl, wherein one or more carbon atoms of the (C 2 -C 28 )alkyl may be optionally replaced with one or more groups independently selected from O, C(═O) and NR c provided that the O or NR c are not adjacent to any other O or NR c .

14. The compound of claim 1 , wherein Y is (C 2 -C 28 )alkyl, wherein one or more carbon atoms of the (C 2 -C 28 )alkyl may be optionally replaced with 1-5 groups independently selected from O and NR c provided that the O or NR c are not adjacent to any other O or NR c .

15. The compound of claim 1 , wherein Y is:

wherein n is 0, 1, 2, 3 or 4;

each Y 1 is independently (C 2 -C 4 )alkyl;

Y 2 is (C 2 -C 6 )alkyl;

Y 3 is —NR Y4 —, —O— or —S—; and

R Y4 is H or (C 1 -C 6 )alkyl.

16. The compound of claim 1 , wherein Y is:

17. The compound of claim 1 , wherein each R a , R b , R c and R d is H.

18. The compound of claim 1 which is:

or a salt thereof.

19. The compound of claim 1 , or a salt thereof, wherein the salt is a pharmaceutically acceptable salt.

20. A composition comprising a compound of claim 1 , or a salt thereof, and an acceptable carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2014
From: JONES, ROGER A.; GAFFNEY, BARBARA L.
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 032821/0911 →
CONFIRMATORY LICENSE Recorded Mar 14, 2014
From: RUTGERS THE STATE UNIV OF NJ NEW BRUNSWICK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032449/0429 →
Continuity (2)
Provisional Application 61733757 · Dec 5, 2012
Related Publication 20140155345A1 · Jun 5, 2014